About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Cdkn1a
cyclin dependent kinase inhibitor 1A
MGI:104556
167 phenotypes from multigenic genotypes
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Apoetm1Unc/Apoetm1Unc
Cdkn1atm1Tyj/Cdkn1atm1Tyj
B6.129-Apoetm1Unc Cdkn1atm1Tyj 		abnormal response/metabolism to endogenous compounds J:125247
abnormal vascular smooth muscle physiology J:125247
decreased susceptibility to atherosclerosis J:125247
decreased susceptibility to induced morbidity/mortality J:125247
delayed cellular replicative senescence J:125247
increased vascular smooth muscle cell proliferation J:125247
Brca1tm1Mak/Brca1tm1Mak
Cdkn1atm1Tyj/Cdkn1atm1Tyj
involves: 129P2/OlaHsd * 129S2/SvPas 		embryonic lethality during organogenesis, complete penetrance J:41254
Brca1tm2.1Cxd/Brca1tm2.1Cxd
Cdkn1atm1Led/Cdkn1atm1Led
involves: 129S6/SvEvTac * 129S7/SvEvBrd * Black Swiss * FVB 		neonatal lethality, complete penetrance J:81559
Brca1tm2Mak/Brca1tm2Mak
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Tg(Lck-cre)548Jxm/?
involves: 129P2/OlaHsd * C57BL/6 * CBA 		decreased thymocyte number J:63282
normal immune system phenotype J:63282
Ccne1tm1Jro/?
Cdkn1atm1Led/Cdkn1atm1Led
either: (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J) or (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * C57BL/6J) 		abnormal cell morphology J:99695
chromosome breakage J:99695
decreased fibroblast proliferation J:99695
Cdkn1atm1(HBsAg)Xya/Cdkn1a+
either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss) 		hepatic steatosis J:88078
increased hepatocellular carcinoma incidence J:88078
Cdkn1atm1(HBsAg)Xya/Cdkn1atm1(HBsAg)Xya
either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss) 		hepatic steatosis J:88078
increased hepatocellular carcinoma incidence J:88078
Cdkn1atm1Hpw/Cdkn1a+
Trp53tm2Wahl/Trp53tm2Wahl
involves: 129S4/SvJae * 129X1/SvJ * C57BL/6 		decreased mortality induced by ionizing radiation J:174375
Cdkn1atm1Led/Cdkn1atm1Led
Cdkn1ctm1Sje/Cdkn1c+
involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 		abnormal axial skeleton morphology J:52552
abnormal bronchiole morphology J:52552
abnormal bronchus morphology J:52552
abnormal ileum morphology J:52552
abnormal jejunum morphology J:52552
abnormal kidney medulla development J:52552
abnormal lens development J:52552
abnormal lens epithelium morphology J:52552
abnormal limb bone morphology J:52552
abnormal long bone epiphysis morphology J:52552
abnormal pulmonary alveolus morphology J:52552
abnormal rib morphology J:52552
abnormal spine curvature J:52552
abnormal sternocostal joint morphology J:52552
abnormal sternum morphology J:52552
cleft palate J:52552
decreased fetal size J:52552
decreased skeletal muscle mass J:52552
herniated abdominal wall J:52552
increased skeletal muscle fiber size J:52552
lethality throughout fetal growth and development, incomplete penetrance J:52552
omphalocele J:52552
perinatal lethality, complete penetrance J:52552
postnatal lethality J:52552
respiratory distress J:52552
rib bifurcation J:52552
short sternum J:52552
small inner medullary pyramid J:52552
split sternum J:52552
thin diaphragm muscle J:52552
Cdkn1atm1Led/Cdkn1atm1Led
Cdkn1ctm2.1Kei/Cdkn1c+
Tg(Mx1-cre)1Cgn/0
B6.Cg-Cdkn1ctm2.1Kei Cdkn1atm1Led Tg(Mx1-cre)1Cgn 		abnormal hematopoietic stem cell physiology J:176209
Cdkn1atm1Led/Cdkn1atm1Led
Ctnnb1tm1Mmt/Ctnnb1tm1Mmt
Tg(Upk2-cre)6Xrw/0
involves: 129S6/SvEvTac * 129X1/SvJ * FVB/N 		increased urinary bladder carcinoma incidence J:234236
premature death J:234236
Cdkn1atm1Led/Cdkn1atm1Led
Fgfr3tm1Cxd/Fgfr3tm1Cxd
involves: 129S6/SvEvTac * NIH Black Swiss 		abnormal long bone epiphyseal plate morphology J:52438
abnormal skeleton morphology J:52438
disproportionate dwarf J:52438
Cdkn1atm1Led/Cdkn1atm1Led
Gadd45atm1Ajf/Gadd45atm1Ajf
either: (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6) 		abnormal chromosome number J:57882
abnormal glomerular capillary endothelium morphology J:76041
abnormal lymphopoiesis J:76041
abnormal T cell activation J:76041
decreased basophil cell number J:76041
decreased eosinophil cell number J:76041
decreased leukocyte cell number J:76041
decreased lymphocyte cell number J:76041
dilated proximal convoluted tubule J:76041
glomerulonephritis J:76041
increased anti-double stranded DNA antibody level J:76041
increased anti-histone antibody level J:76041
increased anti-single stranded DNA antibody level J:76041
increased autoantibody level J:76041
increased fibroblast proliferation J:57882
increased IgG1 level J:76041
increased IgM level J:76041
increased inflammatory response J:76041
increased kidney cell proliferation J:76041
increased mesangial cell number J:76041
increased T cell proliferation J:76041
increased urine protein level J:76041
mesangial cell interposition J:76041
premature death J:76041
Cdkn1atm1Led/Cdkn1atm1Led
Hdac2tm1.2Rdp/Hdac2tm1.2Rdp
involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 		abnormal mitosis J:197818
early cellular replicative senescence J:197818
Cdkn1atm1Led/Cdkn1atm1Led
Hus1tm1Led/Hus1tm1Led
involves: 129S6/SvEvTac 		chromosome breakage J:63869
increased cellular sensitivity to hydroxyurea J:63869
increased cellular sensitivity to ultraviolet irradiation J:63869
Cdkn1atm1Led/Cdkn1atm1Led
Kdm8tm1.2Tasu/Kdm8tm1.2Tasu
involves: 129S4/SvJae * 129S6/SvEvTac * C3H * C57BL/6 		absent vitelline blood vessels J:181189
embryonic growth retardation J:181189
embryonic lethality, complete penetrance J:181189
incomplete embryo turning J:181189
Cdkn1atm1Led/Cdkn1atm1Led
Wrntm1Led/Wrntm1Led
either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * NIH Black Swiss) 		increased tumor incidence J:68488
Cdkn1atm1Led/Cdkn1atm1Led
Zbtb17tm1Cksn/Zbtb17tm1Cksn
Commd10Tg(Vav1-icre)A2Kio/Commd10+
B6.Cg-Zbtb17tm1Cksn Cdkn1atm1Led Commd10Tg(Vav1-icre)A2Kio 		arrested T cell differentiation J:170508
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Cdkn1btm1Ako/Cdkn1btm1Ako
involves: 129S1/Sv * 129S2/SvPas 		abnormal junctional epithelium morphology J:102001
decreased circulating testosterone level J:115443
decreased prostate gland anterior lobe weight J:115443
decreased prostate gland dorsolateral lobe weight J:115443
decreased prostate gland ventral lobe weight J:115443
decreased seminal vesicle weight J:115443
hepatic steatosis J:118516
impaired glucose tolerance J:118516
increased body weight J:115443, J:118516
increased brain weight J:118516
increased brown adipose tissue amount J:118516
increased circulating cholesterol level J:118516
increased food intake J:118516
increased inguinal fat pad weight J:118516
increased kidney weight J:118516
increased lean body mass J:118516
increased parametrial fat pad weight J:118516
increased total body fat amount J:118516
increased white fat cell number J:118516
insulin resistance J:118516
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Cdkn1btm1Mlf/Cdkn1btm1Mlf
involves: 129S2/SvPas * 129S4/SvJaeSor 		abnormal crypts of Lieberkuhn morphology J:111081
abnormal enterocyte proliferation J:111081
abnormal ileum morphology J:111081
abnormal response to injury J:111081
abnormal small intestinal villus morphology J:111081
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Cdkn2atm1Rdp/Cdkn2atm1Rdp
involves: 129/Sv * 129S2/SvPas * C57BL/6 * C57BL/6J * SJL 		abnormal cell physiology J:72780
abnormal keratinocyte physiology J:72780
abnormal skin development J:72780
abnormal skin physiology J:72780
delayed cellular replicative senescence J:72780
increased keratinocyte proliferation J:72780
increased squamous cell carcinoma incidence J:72780
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Cdkn2dtm1Maro/Cdkn2dtm1Maro
involves: 129P2/OlaHsd * 129S2/SvPas * 129X1/SvJ * C57BL/6 * CD-1 		abnormal cochlear hair cell physiology J:118337
abnormal cochlear inner hair cell morphology J:118337
decreased cochlear hair cell number J:118337
decreased cochlear inner hair cell number J:118337
decreased cochlear outer hair cell number J:118337
increased cochlear hair cell number J:118337
polyploidy J:118337
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Csnk1a1tm1.1Ybn/Csnk1a1tm1.1Ybn
Tg(Vil1-cre/ERT2)23Syr/0
involves: 129 * C57BL/6 * CD-1 * DBA/2 		abnormal enterocyte proliferation J:204886
increased carcinoma incidence J:204886
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Fahtm1Mgo/Fahtm1Mgo
involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6 		abnormal hepatocyte morphology J:138701
abnormal liver physiology J:138701
dilated proximal convoluted tubule J:138701
increased hepatocellular carcinoma incidence J:138701
increased hepatocyte apoptosis J:138701
increased hepatocyte proliferation J:138701
increased renal carcinoma incidence J:138701
kidney cyst J:138701
normal mortality/aging J:138701
weight loss J:138701
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Foxk1tm1Djg/Foxk1tm1Djg
involves: 129S2/SvPas * 129S4/SvJae 		normal cellular phenotype J:81688
normal growth/size/body region phenotype J:81688
normal muscle phenotype J:81688
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Gadd45atm1Ajf/Gadd45atm1Ajf
either: (involves: 129P2/OlaHsd) or (involves: 129X1/SvJ) 		decreased cellular sensitivity to ultraviolet irradiation J:101710
normal homeostasis/metabolism phenotype J:101710
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Gata1tm1.1Yen/Gata1tm1.1Yen
involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 * FVB/N 		normal hematopoietic system phenotype J:200716
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Itgb1tm1Mll/Itgb1tm1Mll
Tg(Wap-cre)1Gsc/0
involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * FVB/N 		abnormal mammary gland growth during lactation J:99405
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Mir34atm1.1Lhe/Mir34atm1.1Lhe
involves: 129S2/SvPas * C57BL/6 * C57BL/6J 		abnormal cell physiology J:180692
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Palb2tm1.2Dli/Palb2tm1.2Dli
involves: 129S2/SvPas * 129S4/SvJaeSor * BALB/cJ * C57BL/6 		abnormal embryo development J:197442
fetal growth retardation J:197442
lethality throughout fetal growth and development, complete penetrance J:197442
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Ptentm1Hwu/Ptentm1Hwu
Tg(Fabp1-cre)1Jig/0
involves: 129S2/SvPas * 129S4/SvJae * FVB/N 		abnormal urinary bladder urothelium morphology J:106662
increased urinary bladder carcinoma incidence J:106662
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Rb1tm1Tyj/Rb1+
Tg(Rb1)1Blg/0
involves: 129S2/SvPas 		abnormal xiphoid process morphology J:65679
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Rb1tm1Tyj/Rb1tm1Tyj
Tg(Rb1)1Blg/0
involves: 129S2/SvPas 		abnormal deltoid tuberosity morphology J:65679
abnormal muscle physiology J:65679
abnormal myogenesis J:65679
abnormal posture J:65679
abnormal scapula morphology J:65679
abnormal skeletal muscle fiber morphology J:65679
abnormal sternocostal joint morphology J:65679
abnormal sternum ossification J:65679
abnormal xiphoid process morphology J:65679
absent deltoid tuberosity J:65679
decreased length of long bones J:65679
fragile skeleton J:65679
hemorrhage J:65679
hunched posture J:65679
polyploidy J:65679
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Tg(MMTV-vHaras)SH1Led/0
involves: 129S2/SvPas * C57BL/6J * CD-1 * FVB/N 		decreased tumor latency J:66183
enlarged Harderian gland J:66183
enlarged spleen J:66183
extramedullary hematopoiesis J:66183
Harderian gland hyperplasia J:66183
increased mammary adenocarcinoma incidence J:66183
increased salivary adenocarcinoma incidence J:66183
increased tumor incidence J:66183
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Zfpm2tm1.1Esv/Zfpm2tm1.1Esv
involves: 129S1/SvImJ * 129S2/SvPas * 129S4/SvJae * 129S6/SvEvTac * C57BL/6 		abnormal heart echocardiography feature J:216295
abnormal heart left ventricle wall thickness J:216295
abnormal myocardium compact layer morphology J:216295
atrial septal defect J:216295
postnatal lethality, complete penetrance J:216295
ventricular septal defect J:216295
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
04/23/2024
MGI 6.23 		The Jackson Laboratory